Hemo Organic informs about unaudited financial results

06 Feb 2023 Evaluate

In pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hemo Organic has submitted the followings: Unaudited Standalone Financial Results for the quarter ended on December 31,2022 and Limited Review Report.

The above information is a part of company’s filings submitted to BSE.

Hemo Organic Share Price

12.30 0.14 (1.15%)
29-Apr-2024 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.35
Dr. Reddys Lab 6264.00
Cipla 1398.85
Zydus Lifesciences 964.60
Lupin 1635.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.